'The recommended duration of treatment for rifampin-resistant tuberculosis in programmatic care settings is 9 to 20 months and involves up to 20 tablets per day. Cost, adverse events, and social disruption are prominent challenges. More effective, shorter treatments with a more acceptable side-effect profile are needed.'

#tuberculosis #antibioticresistance #NEJM

https://www.nejm.org/doi/full/10.1056/NEJMoa2117166?query=featured_home